New dialysis access device tested, but study halted early

NCT ID NCT02682420

First seen Jan 07, 2026 · Last updated May 13, 2026 · Updated 18 times

Summary

This study tested a device called everlinQ endoAVF that creates a connection between an artery and vein inside the body for dialysis. It included 100 adults with chronic kidney disease who needed or were about to start dialysis. The study was stopped early, and the main goal was to see how well the connection worked without problems for 6 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Dominikus Hospital

    Düsseldorf, Germany

  • Manchester University NHS Foundation Trust

    Manchester, M13 9WL, United Kingdom

  • Oxford University Hospitals - NHS Foundation Trust

    Headington, Oxford, OX3 9DU, United Kingdom

  • Providence Health Care Society

    Vancouver, British Columbia, V6Z 2K5, Canada

  • St. Franziskus-Hospital Münster

    Münster, Germany

  • St. George's University

    London, United Kingdom

  • University Hospital Carl Gustav Carus

    Dresden, Germany

  • University Hospitals Birmingham

    Birmingham, United Kingdom

  • University of Frankfurt

    Frankfurt, Germany

  • University of Leipzig

    Leipzig, Germany

  • University of Mannheim

    Mannheim, Germany

Conditions

Explore the condition pages connected to this study.